Glucotrack (GCTK) Notes Payables (2010 - 2025)
Glucotrack (GCTK) posted Notes Payables of $3.2 million for Q4 2025, up 4.98% on a QoQ basis from $3.0 million in Q3 2025, and up 63540.0% year-over-year from N/an in Q4 2024.
Glucotrack (GCTK) Notes Payables (2010 - 2025) Analysis & Trends
Glucotrack's Notes Payables history runs 6 years deep, the most recent figure standing at $3.2 million for Q4 2025.
- Quarterly Notes Payables rose 63540.0% year-over-year to $3.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.2 million (up 63540.0% YoY) and the FY2025 annual result came in at $3.2 million, up 63540.0% from the prior year.
- Notes Payables was $3.2 million for Q4 2025 at Glucotrack, up from $3.0 million in the prior quarter.
- Across five years, Notes Payables topped out at $3.2 million in Q4 2025 and bottomed at $5000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Glucotrack | 33.48 | -7.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.18 Mn |
| Sep 30, 2025 | 3.03 Mn |
| Mar 31, 2025 | 9,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2014 | 23,838.00 |
| Dec 31, 2012 | 37,427.00 |
| Sep 30, 2012 | 50,980.00 |
| Mar 31, 2011 | 29,890.00 |
| Dec 31, 2010 | 18,843.00 |